Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
8-day open-label multiple-dose pharmacokinetic and safety study of aliskiren in hypertensive children and adolescents
2008-005802-37Phase 2Completed
- Sponsor
- Novartis
- Start
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aliskiren in hypertension (HTN), sponsored by Novartis. Started Feb 2009; status: completed.
02
Drugs
aliskiren
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2008-005802-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005802-37.